<SEC-DOCUMENT>0000950170-25-021601-index.html : 20250214
<SEC-HEADER>0000950170-25-021601.hdr.sgml : 20250214
<ACCEPTANCE-DATETIME>20250214183040
ACCESSION NUMBER:		0000950170-25-021601
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250214
DATE AS OF CHANGE:		20250214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-77907
		FILM NUMBER:		25631688

	BUSINESS ADDRESS:	
		STREET 1:		804, 322 - 11 AVENUE SW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2R 0C5
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		804, 322 - 11 AVENUE SW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2R 0C5

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anson Funds Management LP
		CENTRAL INDEX KEY:			0001491072
		ORGANIZATION NAME:           	
		IRS NUMBER:				300134498
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		16000 DALLAS PARKWAY
		STREET 2:		SUITE 800
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75248
		BUSINESS PHONE:		214.866.0202

	MAIL ADDRESS:	
		STREET 1:		16000 DALLAS PARKWAY
		STREET 2:		SUITE 800
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75248

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Frigate Ventures LP
		DATE OF NAME CHANGE:	20100504
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ck0001669811-ex99_1.pdf
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: ck0001669811-ex99_1.pdf

</DOCUMENT>
</SEC-DOCUMENT>